Spotlight On Metastatic Castration-Resistant Prostate Cancer
Showcasing the latest news and clinical breakthroughs, Spotlight on Metastatic Castration-Resistant Prostate Cancer delves into the complexities of managing this advanced disease. Tune in to hear oncologists and urologists share their insights on recent clinical trials, treatment advancements, management strategies, and more.
Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Project Oncology®Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
Project Oncology®Navigating mCRPC Treatment: A Look at Abiraterone and Enzalutamide
How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
Project Oncology®How PSMA Scans Inform Metastatic Prostate Cancer Diagnosis and Treatment
Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Project Oncology®Radium-223’s Potential Quality of Life Benefits for mCRPC Patients
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Project Oncology®Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Project Oncology®mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
- 03/19/2025
pubmed.ncbi.nlm.nih.gov
06/18/2024- miragenews.com
05/27/2024
- news.northwestern.edu
05/01/2024
- news.nd.edu
04/30/2024
- insideprecisionmedicine.com
04/19/2024